
     


General Information
Oxycodone
is an opioid derived from an alkaloid of opium, thebaine. It
was first synthesized in the early twentieth century, some sources indicating
the year 1916. We do know that oxycodone has been available in Europe
for oral and intravenous use since 1917, but some historians believe
it was one year earlier. The drug was released in the United States during
the 1950s.[1] Some prescription drugs
containing oxycodone include Percocet, Percodan, Roxicet, OxyContin,
and Roxicodone. The effects most sought after are pain relief, euphoria,
reduction in anxiety, and sedation. Other side effects can include constipation,
and dizziness. Many users report feeling itchy after ingesting oxycodone;
this results from the release of histamine in the brain.
In 1995, OxyContin, which is manufactured
by Purdue and allows up to 12 hours of continuous pain relief, was approved
for sale. OxyContin is available in 10, 20, 40, and 80 milligram pills.
When it was first released on the market, a 160 milligram pill was manufactured,
but Purdue eventually pulled it off the market. On the streets OxyContin
is referred to as OC, hillbilly heroin, oxy, jawns, jimmies, "big
guys" (refers to the 80 milligram pills), itchies, "Ocean City," or "Orange
County." The growing OxyContin problem has become an epidemic in many
parts of the United States. In southeastern Pennsylvania, users have been
witnessed paying $80 for one 80 mg OxyContin pill. As habits grow, many
people switch to heroin because
of its availability and attractively lower prices.
FAST FACTS:
- Oxycodone is not tested for in a standard drug screening; however,
at very high doses it may cause a positive for opiates. It is typically
in the urine for 3-4 days. Very rarely is it a part of extended drug
screening.
- Oxycodone is addicting, and causes tolerance. Moderate use is hard
to maintain with any opiate. Most people who say they will "only use
once a week" end up using more often than they want to. Using opiates
on a regular basis will cause a physical and possibly mental dependency.
After using oxycodone for a few days, a larger dose is often needed to
achieve the same effects.
- Those who have never done opiates or without a tolerance need to exercise
extreme caution when dosing. It is not recommended that anyone take oxycodone
without a proper prescription. Users beware, what one person can tolerate
may kill another person.
Chemical Names. (5a)-4,5-epoxy-14-hydroxy-3-methoxy-17-
methylmorphinan-6-one.
Classification. Opioid.
Primary Uses. Analgesia.
Other Names. OxyContin,
Percocet, Percodan, Roxicodone, Roxicet, Endocet.
Urinalysis Detection Time. 3-4 days.
Pharmacology and Pharmacokinetics
Administration
Route |
Bioavailability
(Median) |
|
46-47% |
|
60-87% |
Rectal |
60-87% |
Law
In
the United States, oxycodone is a Schedule II substance, making it illegal
to use/possess without a prescription. Schedule II substances, such as
dextroamphetamine, morphine,
and cocaine, meet the following criteria according to the Controlled
Substances Act:
- The drug or other substance has a high potential
for abuse.
- The drug or other substance has a currently accepted
medical use in treatment in the United States (or) a currently accepted
medical use with severe restrictions.
- Abuse of the drug may lead to severe psychological
or physical dependence.
Side Effects
- Pain relief
- Euphoria/dysphoria
- Mood changes
- Reduced anxiety
- Sedation
- Itching
- Nausea/vomiting
- Decreased libido (sex drive)
- Constipation
- Facial flushing
- Vertigo
Withdrawal
Oxycodone, in any form, is highly addictive,
and many users eventually become mentally and physically dependent. Withdrawal typically
begins within 24-36 hours after the last dose, though it can start
sooner for chronic users, and peaks in intensity around 72-96 hours. Withdrawal
symptoms can include gooseflesh, restless legs/arms, anxiety, nausea,
vomiting, depression, muscle aches, insomnia, diarrhea, headache, and
dilated pupils.
Additional Information
Books
Sources
[1] Drew Pinsky, M.D., Marvin D. Seppala, M.D., Robert
J. Meyers, Ph.D., John Gardin, Ph.D., William White, M.A., Stephanie Brown,
Ph.D. When Painkillers Become Dangerous. Center City, Minnesota:
Hazelden, 2004. pg 6.
[2] Takala A, Kaasalainen V, Seppala T, Kalso E, Olkkola
KT. Pharmacokinetic comparison of intravenous and intranasal administration
of oxycodone. Entrez PubMed [9062618]. Acta Anaesthesiol
Scand. 1997 Feb;41(2):309-12. [link]
Accessed: October 25, 2006.
[3] Oxycodone HCl: Clinical Pharmacology.
RxList. 2006. [link]
Accessed: October 25, 2006. |